Status:
UNKNOWN
Prediction Model of Improvement of Disturbance of Consciousness in Patients With Hydrocephalus After Shunt Operation
Lead Sponsor:
Zhuohang Wang
Conditions:
Disorder of Consciousness
Hydrocephalus
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Patients with hydrocephalus are usually treated with cerebrospinal fluid (CFS) shunt to deal with excess cerebrospinal fluid in the brain. However, it is difficult to distinguish whether ventricular e...
Detailed Description
Among them, imaging parameters include: Evans index, EI; Callosal angle, CA; Z-Evans index, Z-EI; Brain/ventricle ratio, BVR; Frontal horn ratio, FHR; Frontal and occipital horn ratio, FOR/FOHR; Fron...
Eligibility Criteria
Inclusion
- Age ≥18, gender is not limited.
- Patients with traffic hydrocephalus caused by various reasons, including atmospheric hydrocephalus, who need cerebrospinal fluid shunt and meet the surgical indications to a certain extent.
- Typical imaging manifestations of hydrocephalus patients.
- Clinical manifestations of consciousness disorder.
- Whether or not you can participate in the study will be decided after a doctor's examination.
Exclusion
- patients with mental or motor disorders, such as Alzheimer's disease, schizophrenia, and Parkinson's disease.
- Patients with abnormal coagulation mechanism or receiving treatment with thrombolysis agent, anticoagulant or platelet coagulant inhibitor and hemophilia.
- Patients with serious diseases of other systems, such as serious diseases of blood system, respiratory system, digestive system, urinary system and immune system, as well as patients with mental disorders and recent history of intracranial infection.
- Patients with a known disease causing ventricle enlargement.
- Female patients in pregnancy and lactation.
- Other circumstances in which the doctor judges that he cannot participate in the test.
- The subject himself or his legal representative refuses to participate in the clinical trial. Whether you are suitable to participate in this study needs the final decision after doctor's examination.
Key Trial Info
Start Date :
April 10 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 10 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05237102
Start Date
April 10 2022
End Date
December 10 2022
Last Update
February 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China